These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19106169)

  • 1. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.
    Kawai M; Hagihara K; Hirano T; Shima Y; Kuwahara Y; Arimitsu J; Narazaki M; Ogata A; Kawase I; Kishimoto T; Tanaka T
    Rheumatology (Oxford); 2009 Mar; 48(3):318-9. PubMed ID: 19106169
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade.
    Wallace ZS; Stone JH
    J Rheumatol; 2013 Jan; 40(1):100-1. PubMed ID: 23280172
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis.
    Narshi CB; Allard SA
    Rheumatology (Oxford); 2012 May; 51(5):952-3. PubMed ID: 22298790
    [No Abstract]   [Full Text] [Related]  

  • 4. Relapsing polychondritis: response to tocilizumab and association with colitis.
    Plunkett M; Lamont D; Brooker J; White D
    J Clin Rheumatol; 2013 Oct; 19(7):415-7. PubMed ID: 24048111
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of relapsing polychondritis with tocilizumab.
    Wendling D; Godfrin-Valnet M; Prati C
    J Rheumatol; 2013 Jul; 40(7):1232. PubMed ID: 23818726
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sustained response with tocilizumab in a case of refractory relapsing polychondritis].
    Weber E; Gaultier JB; Paul S; Guichard I; Monard E; Cathébras P
    Rev Med Interne; 2014 Mar; 35(3):196-8. PubMed ID: 24074969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with tocilizumab for refractory scleritis associated with relapsing polychondritis.
    Shimizu H; Nishioka H
    Scand J Rheumatol; 2017 Sep; 46(5):418-419. PubMed ID: 28120637
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained Remission with Tocilizumab in Refractory Relapsing Polychondritis with Ocular Involvement: A Case Series.
    Farhat R; Clavel G; Villeneuve D; Abdelmassih Y; Sahyoun M; Gabison E; Sené T; Cochereau I; Titah C
    Ocul Immunol Inflamm; 2021 Jan; 29(1):9-13. PubMed ID: 32643976
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of tocilizumab therapy in a patient with mouth and genital ulcers with inflamed cartilage syndrome complicated by aortic aneurysm.
    Terreaux W; Mestrallet S; Fauconier M; Pennaforte JL; Penalba C; Eschard JP; Salmon JH
    Rheumatology (Oxford); 2015 Nov; 54(11):2111-3. PubMed ID: 26175469
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of adalimumab for a refractory case of relapsing polychondritis with reduction of pro-inflammatory cytokines.
    Nakamura H; Suzuki T; Nagaoka K; Yamasaki S; Tamai M; Hayashi T; Kawakami A
    Mod Rheumatol; 2011 Dec; 21(6):665-8. PubMed ID: 21509650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis.
    Seymour MW; Home DM; Williams RO; Allard SA
    Rheumatology (Oxford); 2007 Nov; 46(11):1738-9. PubMed ID: 17933796
    [No Abstract]   [Full Text] [Related]  

  • 12. Tocilizumab for refractory relapsing polychondritis-long-term response monitoring by magnetic resonance imaging.
    Henes JC; Xenitidis T; Horger M
    Joint Bone Spine; 2016 May; 83(3):365-6. PubMed ID: 26750763
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature.
    Liu L; Liu S; Guan W; Zhang L
    Rheumatol Int; 2016 Aug; 36(8):1185-9. PubMed ID: 27260262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.
    Nishimoto N; Nakahara H; Yoshio-Hoshino N; Mima T
    Arthritis Rheum; 2008 Apr; 58(4):1197-200. PubMed ID: 18383395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained response to tocilizumab in a patient with relapsing polychondritis complicated by aortitis.
    Sallés M; Mínguez S; Ros S; Tuneu R; Gelman SM
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):223. PubMed ID: 28229816
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Tanaka T; Hagihara K; Shima Y; Narazaki M; Ogata A; Kawase I; Kishimoto T
    Rheumatology (Oxford); 2010 Apr; 49(4):824-6. PubMed ID: 20008092
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia.
    Subrahmanyam P; Balakrishnan C; Dasgupta B
    Scand J Rheumatol; 2008; 37(3):239-40. PubMed ID: 18465465
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.
    Cañas CA; Cañas F; Izquierdo JH; Echeverri AF; Mejía M; Bonilla-Abadía F; Tobón GJ
    J Clin Rheumatol; 2014 Apr; 20(3):125-9. PubMed ID: 24662551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical benefits of anti-human IL-6 receptor antibody therapy].
    Nishimoto N
    Clin Calcium; 2007 Apr; 17(4):562-8. PubMed ID: 17404486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained response to infliximab in 2 patients with refractory relapsing polychondritis.
    Saadoun D; Deslandre CJ; Allanore Y; Pham XV; Kahan A
    J Rheumatol; 2003 Jun; 30(6):1394-5. PubMed ID: 12784426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.